Glycerin
- Generic Name
- Glycerin
- Brand Names
- Clear Eyes Cooling Comfort, Clear Eyes Redness Relief Reformulated Nov 2011, Fleet Mineral Oil, Genteal Tears, Glycerolyte 57, Pedia-lax Liquid, Preparation H Cream, Procalamine 3, Refresh Optive Advanced, Refresh Optive Extended Therapy, Synovisol, Tears Lubricant
- Drug Type
- Small Molecule
- Chemical Formula
- C3H8O3
- CAS Number
- 56-81-5
- Unique Ingredient Identifier
- PDC6A3C0OX
- Background
A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism.
- Indication
It is used as a solvent, emollient, pharmaceutical agent, and sweetening agent.
- Associated Conditions
- Cold Sore, Constipation, Dry Mouth, Dry Skin, Dry throat, Edema of the cerebrum, Increase in Intracranial Pressure (ICP), Occasional Constipation, Ocular Discomfort, Ocular Hypertension, Ocular Irritation, Skin Infections, Sore Throat, Mouth soreness, Sensation of burning in the eyes
- Associated Therapies
- Bowel preparation therapy, Topical Antisepsis, Skin protection
An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders
- Conditions
- Autistic DisorderEncopresis
- Interventions
- First Posted Date
- 2015-03-09
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Emory University
- Target Recruit Count
- 22
- Registration Number
- NCT02383758
- Locations
- 🇺🇸
Marcus Autism Center, Atlanta, Georgia, United States
FARE Peanut SLIT and Early Tolerance Induction
- Conditions
- Food HypersensitivityPeanut AllergyPeanut HypersensitivityFood Allergy
- Interventions
- First Posted Date
- 2014-12-02
- Last Posted Date
- 2022-01-10
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 50
- Registration Number
- NCT02304991
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Glycerin Suppositories Used Prophylactically in Premature Infants (SUPP): a Pilot Randomized Placebo-controlled Trial
- Conditions
- Feeding Intolerance in Premature Infants
- Interventions
- Other: Sham Suppository
- First Posted Date
- 2014-06-03
- Last Posted Date
- 2016-03-17
- Lead Sponsor
- McMaster University
- Target Recruit Count
- 30
- Registration Number
- NCT02153606
- Locations
- 🇨🇦
McMaster University Medical Centre, Hamilton, Ontario, Canada
Glycerin Suppositories for Treatment of Feeding Intolerance in Preterm Infants
- Conditions
- Feeding Intolerance
- Interventions
- First Posted Date
- 2014-05-29
- Last Posted Date
- 2015-04-03
- Lead Sponsor
- King Saud Medical City
- Target Recruit Count
- 230
- Registration Number
- NCT02149407
- Locations
- 🇸🇦
King Saud Medical City, Riyadh, Saudi Arabia
🇸🇦Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia
Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media
- First Posted Date
- 2014-01-24
- Last Posted Date
- 2015-04-08
- Lead Sponsor
- Arbor Pharmaceuticals, Inc.
- Target Recruit Count
- 304
- Registration Number
- NCT02044341
- Locations
- 🇺🇸
PMG Research of Bristol, Bristol, Tennessee, United States
🇺🇸The Iowa Clinic, Pc, West Des Moines, Iowa, United States
🇺🇸Clinical Research Center, Las Vegas, Nevada, United States
Efficacy of Prophylactic Glycerin Suppositories for Feeding Intolerance in Very Low Birth Weight Preterm Infants: a Randomized Trial
- Conditions
- Infant, Very Low Birth Weight
- Interventions
- First Posted Date
- 2013-02-27
- Last Posted Date
- 2024-03-06
- Target Recruit Count
- 220
- Registration Number
- NCT01799629
- Locations
- 🇸🇦
King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
🇸🇦Sulaiman Al habib Medical Center, Riyadh, Saudi Arabia
🇸🇦Security Forces Hospital, Riyadh, Saudi Arabia
Glycerin Suppositories to Reduce Jaundice in Premature Infants
- Conditions
- Idiopathic HyperbilirubinemiaNeonatal HyperbilirubinemiaPrematurity
- Interventions
- Procedure: Phototherapy
- First Posted Date
- 2012-12-11
- Last Posted Date
- 2015-12-09
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 79
- Registration Number
- NCT01746511
- Locations
- 🇺🇸
University of Rochester Medical Center NICU, Rochester, New York, United States
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
- Conditions
- Constipation
- Interventions
- First Posted Date
- 2011-11-18
- Last Posted Date
- 2012-09-25
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 300
- Registration Number
- NCT01474499
- Locations
- 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China
🇨🇳The Second Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
Investigation of KLYX in Patients With Constipation
- First Posted Date
- 2011-04-14
- Last Posted Date
- 2012-02-06
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 60
- Registration Number
- NCT01335386
- Locations
- 🇨🇳
Changhai Hospital, The Second Military Medical University, Shanghai, China
🇨🇳Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
🇨🇳Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Assessing Maternal Post-partum Pain With Suppositories
- Conditions
- Pain
- Interventions
- First Posted Date
- 2011-01-07
- Last Posted Date
- 2018-03-07
- Lead Sponsor
- Loyola University
- Target Recruit Count
- 100
- Registration Number
- NCT01271855
- Locations
- 🇺🇸
Gottlieb Memorial Hospital, Melrose Park, Illinois, United States
🇺🇸Loyola Univeristy Medical Center, Maywood, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.